Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 17 | 2024 | 1228 | 4.850 |
Why?
|
| Telemedicine | 6 | 2024 | 426 | 2.650 |
Why?
|
| Community Health Workers | 5 | 2024 | 62 | 2.480 |
Why?
|
| Diabetes Mellitus | 6 | 2025 | 849 | 1.880 |
Why?
|
| Hypoglycemic Agents | 6 | 2024 | 426 | 1.790 |
Why?
|
| Cardiovascular Diseases | 10 | 2025 | 1863 | 0.920 |
Why?
|
| Metformin | 3 | 2024 | 147 | 0.860 |
Why?
|
| Self-Management | 1 | 2024 | 96 | 0.830 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 451 | 0.730 |
Why?
|
| Patient Selection | 1 | 2023 | 685 | 0.680 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 122 | 0.640 |
Why?
|
| House Calls | 1 | 2019 | 37 | 0.620 |
Why?
|
| Medically Underserved Area | 1 | 2019 | 92 | 0.600 |
Why?
|
| Psychotherapy, Group | 1 | 2017 | 50 | 0.570 |
Why?
|
| Poverty | 4 | 2023 | 419 | 0.570 |
Why?
|
| Patient Care Team | 1 | 2017 | 548 | 0.430 |
Why?
|
| Humans | 34 | 2025 | 123223 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 826 | 0.420 |
Why?
|
| Sulfonylurea Compounds | 2 | 2024 | 16 | 0.400 |
Why?
|
| Cardiology | 4 | 2024 | 472 | 0.380 |
Why?
|
| Thiazolidinediones | 2 | 2024 | 79 | 0.380 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 3 | 2024 | 65 | 0.310 |
Why?
|
| Quality of Life | 4 | 2024 | 1929 | 0.310 |
Why?
|
| Adult | 9 | 2024 | 29072 | 0.300 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2023 | 714 | 0.260 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 1151 | 0.240 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2024 | 25 | 0.230 |
Why?
|
| Middle Aged | 8 | 2024 | 26016 | 0.220 |
Why?
|
| Community Health Centers | 1 | 2023 | 39 | 0.220 |
Why?
|
| Primary Prevention | 1 | 2024 | 164 | 0.210 |
Why?
|
| American Heart Association | 1 | 2025 | 295 | 0.210 |
Why?
|
| Feedback | 1 | 2023 | 162 | 0.210 |
Why?
|
| Publishing | 1 | 2024 | 108 | 0.200 |
Why?
|
| Male | 11 | 2025 | 60117 | 0.200 |
Why?
|
| Health Education | 1 | 2024 | 225 | 0.200 |
Why?
|
| Research Design | 2 | 2023 | 685 | 0.190 |
Why?
|
| Female | 11 | 2025 | 65549 | 0.190 |
Why?
|
| Pediatric Obesity | 2 | 2017 | 379 | 0.190 |
Why?
|
| Anticholesteremic Agents | 1 | 2023 | 230 | 0.180 |
Why?
|
| Multimorbidity | 1 | 2020 | 20 | 0.180 |
Why?
|
| Veterans | 2 | 2022 | 1726 | 0.170 |
Why?
|
| Goals | 1 | 2021 | 130 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 420 | 0.170 |
Why?
|
| Health Status Indicators | 1 | 2020 | 120 | 0.170 |
Why?
|
| Mentors | 1 | 2021 | 144 | 0.170 |
Why?
|
| Insulins | 1 | 2020 | 17 | 0.170 |
Why?
|
| Weight Reduction Programs | 1 | 2020 | 57 | 0.170 |
Why?
|
| Videoconferencing | 1 | 2019 | 21 | 0.160 |
Why?
|
| Telephone | 1 | 2019 | 110 | 0.160 |
Why?
|
| Medicaid | 1 | 2021 | 245 | 0.160 |
Why?
|
| Group Processes | 1 | 2019 | 47 | 0.160 |
Why?
|
| Behavior Therapy | 1 | 2021 | 256 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2019 | 338 | 0.150 |
Why?
|
| Cost of Illness | 1 | 2020 | 242 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2025 | 973 | 0.150 |
Why?
|
| Algorithms | 1 | 2025 | 1593 | 0.150 |
Why?
|
| Diabetes Complications | 1 | 2019 | 196 | 0.150 |
Why?
|
| Administration, Oral | 1 | 2020 | 670 | 0.150 |
Why?
|
| Body Mass Index | 3 | 2020 | 1541 | 0.140 |
Why?
|
| Life Style | 4 | 2021 | 402 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2021 | 1388 | 0.140 |
Why?
|
| Seasons | 1 | 2017 | 303 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 771 | 0.130 |
Why?
|
| Weight Loss | 4 | 2021 | 478 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2021 | 1325 | 0.130 |
Why?
|
| Child Behavior | 1 | 2017 | 232 | 0.130 |
Why?
|
| Acculturation | 1 | 2015 | 68 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 594 | 0.120 |
Why?
|
| Body Weight | 2 | 2017 | 1001 | 0.120 |
Why?
|
| Aged | 5 | 2024 | 19098 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2017 | 753 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2022 | 831 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2019 | 1119 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2023 | 4710 | 0.110 |
Why?
|
| Pandemics | 1 | 2022 | 1101 | 0.110 |
Why?
|
| Obesity | 3 | 2021 | 2226 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1414 | 0.110 |
Why?
|
| Congresses as Topic | 2 | 2024 | 170 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 5049 | 0.100 |
Why?
|
| Overweight | 3 | 2021 | 357 | 0.100 |
Why?
|
| United States | 5 | 2025 | 10637 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3670 | 0.090 |
Why?
|
| Depression | 1 | 2019 | 1217 | 0.090 |
Why?
|
| Texas | 1 | 2019 | 3560 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12141 | 0.060 |
Why?
|
| Minimal Clinically Important Difference | 1 | 2023 | 7 | 0.060 |
Why?
|
| Europe | 1 | 2024 | 374 | 0.060 |
Why?
|
| Editorial Policies | 1 | 2024 | 52 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2023 | 67 | 0.050 |
Why?
|
| Writing | 1 | 2024 | 59 | 0.050 |
Why?
|
| Exercise | 2 | 2020 | 808 | 0.050 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 68 | 0.050 |
Why?
|
| Data Collection | 1 | 2023 | 386 | 0.050 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2021 | 52 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2022 | 135 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 678 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2023 | 218 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 238 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2023 | 557 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2020 | 90 | 0.040 |
Why?
|
| Risk Factors | 2 | 2024 | 10015 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2020 | 84 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2017 | 16033 | 0.040 |
Why?
|
| Global Health | 1 | 2023 | 557 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 872 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2021 | 387 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 153 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1168 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2019 | 753 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 1068 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6372 | 0.020 |
Why?
|
| Child | 2 | 2017 | 24240 | 0.020 |
Why?
|